Canagliflozin attenuates cognitive deficits in the streptozotocin-induced mouse model of sporadic Alzheimer's disease via modulating PINK1/Parkin signaling pathway and miR-34a expression.

Saved in:
Bibliographic Details
Title: Canagliflozin attenuates cognitive deficits in the streptozotocin-induced mouse model of sporadic Alzheimer's disease via modulating PINK1/Parkin signaling pathway and miR-34a expression.
Authors: Nadeem RI; Pharmacology and Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt. Electronic address: rania.ibrahim@hu.edu.eg., Sayed RH; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, Egypt; Clinical Pharmacy Department, School of Pharmacy, Newgiza University, Giza, Egypt., Elbaz EM; Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt., Abdel Rahman AAS; Department of Zoology, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo, Egypt., Saeed MM; Lecturer of Pharmacology and Toxicology, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.
Source: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2026 Jun 11; Vol. 148, pp. 111781. Date of Electronic Publication: 2026 Jun 11.
Publication Type: Journal Article
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 8211617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4216 (Electronic) Linking ISSN: 02785846 NLM ISO Abbreviation: Prog Neuropsychopharmacol Biol Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-4216
DOI:10.1016/j.pnpbp.2026.111781